Smarter prophylaxis: How RHD testing protects patients and resources
The supply of anti-D immunoglobulin, a prophylactic cornerstone of maternal care, has come under...
Devyser Genomic Blood Typing is a streamlined NGS solution for comprehensive genetic blood typing. This all-in-one kit empowers laboratories to accurately identify red blood cell (RBC), human platelet antigen (HPA), and human neutrophil antigen (HNA) profiles in a single, efficient assay. It provides high-resolution molecular blood typing with a simple workflow and minimal hands-on time.
Devyser Genomic Blood Typing – Product features
Devyser Genomic Blood Typing combines the benefits of NGS with streamlined efficiency to deliver fast, accurate results that save time and reduce complexity.
Detects RBC, HPA, and HNA systems in one test - Identifies major and minor blood group antigens, including ABO, Rh, Kell, Duffy, Kidd, and MNS systems, as well as platelet and neutrophil antigens. Devyser’s genetic blood typing approach ensures robust, reliable results, even for rare and weak variants.
Streamlined single-tube workflow
Minimizes manual handling, maximizes efficiency - The innovative single-tube design enables NGS testing in any laboratory, powered by an extremely short hands-on time and a total assay time for NGS library preparation of five hours. The optimized protocol reduces error risk and is easily scalable for higher throughput.
Turn complex sequencing data into clear insights - Advyser Blood Suite simplifies variant analysis and interpretation, even for laboratories without in-house bioinformatics expertise. Identified blood cell antigens are outlined according to ISBT standards, and regular updates ensure compatibility with ISBT blood group databases for ongoing accuracy
Scalable and automation-friendly
Fits seamlessly into modern laboratory workflows - Compatible with major NGS platforms like the Illumina MiSeq and suitable for batch processing, Devyser Genomic Blood Typing supports high-throughput research environments, from transfusion centers to transplantation research programs.
Why choose Devyser Genomic Blood Typing?
Serological methods alone can leave some ambiguity in results, especially in cases of weak antigen expression, diverse ethnic backgrounds, or rare subvariants. Devyser Genomic Blood Typing complements serology by providing high-resolution, NGS insight into red blood cell, platelet, and neutrophil antigens.
Learn how Devyser Genomic Blood Typing can transform your research workflows with simplicity, scalability, and precision.
Instructions for use
Enter access code found in the lower right corner of the label on the kit box.
Certificates
Download a specific Batch Release Certificate (BRC) below.
Guidelines and handbooks (1)
Product information (0)
Software settings (3)
Safety data sheets (1)
Data tables (0)
Enter access code found in the lower right corner of the label on the kit box.
Download a specific Batch Release Certificate (BRC) below.
RUO
Devyser Genomic Blood Typing
Redefining blood typing, simplifying complexity
8-A419-24-RUO
8-A419-96-RUO
Pack size: 24
Pack size: 96
What antigens are covered by Devyser Genomic Blood Typing?
The kit covers most relevant RBC, HPA, and HNA antigens, including groups like ABO, Rh, Kell, Kidd, Duffy, and MNS.
How long does the workflow take?
The total time for NGS library preparation is approximately five hours, and thanks to the simple one-tube workflow, less than 45 minutes of hands-on time is required.
Is bioinformatics expertise required to analyze this product?
No. Devyser provides dedicated software, Advyser Blood Suite, which handles data analysis and interpretation and does not require advanced bioinformatics skills.
What sample types are needed?
Can Devyser Genomic Blood Typing be used in diagnostic testing?
No. This product is for research use only (RUO) and is not intended for diagnostic purposes.
The supply of anti-D immunoglobulin, a prophylactic cornerstone of maternal care, has come under...
Read More
Over the past decade, there has been a wealth of research investigating the ideal approach to RHD...
Read More
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
Read More
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...
Read More